Table 1.
Baseline characteristics of patients with COVID-19.
|
Overall (n = 204) |
ECG changes (n = 36) |
No ECG changes (n = 168) |
p | |
|---|---|---|---|---|
| Age (years) | 64 ± 13 | 67 ± 13 | 63 ± 13 | 0.14 |
| Gender (% male) | 156 (76%) | 25 (69%) | 131 (78%) | 0.28 |
| Race | 0.08 | |||
| African-American | 10 (5%) | 4 (11%) | 6 (4%) | |
| Non-AA | 191 (95%) | 31 (89%) | 160 (96%) | |
| Weight (kg) | 86.6 ± 17.6 | 83.7 ± 16.4 | 87.3 ± 17.8 | 0.25 |
| CAD | 25 (12%) | 7 (19%) | 18 (11%) | 0.16 |
| HTN | 114 (56%) | 20 (56%) | 94 (56%) | 1 |
| CKD | 17 (8%) | 6 (17%) | 11 (7%) | 0.09 |
| DM | 61 (30%) | 18 (50%) | 43 (26%) | <0.01 |
| COPD | 13 (6%) | 4 (11%) | 9 (5%) | 0.25 |
| CHF | 7 (3%) | 2 (6%) | 5 (3%) | 0.61 |
| Initial creatinine (mg/dL) | 1.3 ± 1.0 | 1.6 ± 1.4 | 1.2 ± 0.9 | 0.57 |
| Abnormal LFTs | 48 (25%) | 10 (29%) | 38 (24%) | 0.51 |
| Initial troponin (ng/mL) | 0.02 (0.01 - 0.04) |
0.02 (0.01 - 0.08) |
0.02 (0.01 - 0.04) |
0.17 |
| Maximum troponin | 0.04 (0.01 - 0.15) |
0.12 (0.02 - 0.47) |
0.03 (0.01 - 0.11) |
0.01 |
| Troponin group | <0.01 | |||
| ≤ 0.05 | 120 (59%) | 14 (39%) | 106 (63%) | |
| 0.05–1.00 | 64 (31%) | 14 (39%) | 50 (30%) | |
| >1.00 | 20 (10%) | 8 (22%) | 12 (7%) | |
| Mortality | 50 (23%) | 13 (36%) | 37 (22%) | 0.09 |